OTTMUSG00000010438 Activators
Pramef17 is a protein that plays a crucial role in various cellular processes, and its activation is essential for maintaining cellular homeostasis. This protein is known to be involved in signaling pathways related to cell growth, differentiation, and metabolism. Pramef17 acts as a transcriptional regulator and influences the expression of genes involved in these processes. Activation of Pramef17 is a complex process, and it can be influenced by several chemical activators. Some of the chemicals listed above directly activate Pramef17, while others indirectly modulate its activity through different signaling pathways. Direct activators like Forskolin and Resveratrol directly interact with Pramef17 or its associated proteins, leading to functional activation. Forskolin stimulates adenylate cyclase, resulting in increased cAMP levels, which activate Pramef17 through the cAMP-dependent protein kinase (PKA) pathway. Resveratrol, on the other hand, influences SIRT1, a deacetylase enzyme, which in turn activates Pramef17 through deacetylation.
Indirect activators such as Curcumin and Epinephrine affect Pramef17 by modulating upstream pathways. Curcumin inhibits NF-κB activation, a negative regulator of Pramef17, indirectly leading to its activation. Epinephrine activates Pramef17 through the beta-adrenergic receptor pathway, initiating a signaling cascade that ultimately activates Pramef17. These chemicals and their respective mechanisms of activation highlight the diverse ways in which Pramef17 can be functionally activated. Understanding these activation mechanisms is crucial for further research into the role of Pramef17 in cellular processes and its potential implications in various biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences SIRT1, a deacetylase enzyme that modulates Pramef17 activity through deacetylation. This deacetylation activates Pramef17, enhancing its functionality in cellular processes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin stimulates Pramef17 indirectly by inhibiting NF-κB activation, which is a negative regulator of Pramef17. By blocking NF-κB, curcumin indirectly activates Pramef17, enhancing its function. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine activates Pramef17 through the beta-adrenergic receptor pathway. Binding of epinephrine to its receptor triggers a signaling cascade that ultimately leads to the activation of Pramef17. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) activates Pramef17 via the EP2 receptor and subsequent activation of the cAMP/PKA pathway. This pathway results in the functional activation of Pramef17 in various cellular processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces calcium release from the endoplasmic reticulum, leading to the activation of Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII, in turn, activates Pramef17 through phosphorylation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), which then activates Pramef17 through phosphorylation. This activation enhances the functionality of Pramef17 in cellular metabolic processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
12-O-Tetradecanoylphorbol-13-acetate (TPA) activates Pramef17 indirectly by activating PKC, which phosphorylates and activates Pramef17. This results in the functional activation of Pramef17 in cellular processes. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin activates Pramef17 by inhibiting histone deacetylases (HDACs), which leads to increased histone acetylation. Enhanced histone acetylation activates Pramef17, promoting its function in gene expression regulation. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 activates Pramef17 by inhibiting MEK1, a negative regulator of Pramef17. Inhibition of MEK1 leads to the functional activation of Pramef17, enhancing its role in various cellular processes. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene activates Pramef17 indirectly by modulating intracellular calcium levels. This modulation of calcium levels indirectly activates Pramef17, enhancing its functionality in muscle and cellular processes. | ||||||